blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1169302

EP1169302 - N-(2-PHENYL-4-AMINO-BUTYL)-1-NAPHTHAMIDES AS NEUROKININ-1 RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.08.2005
Database last updated on 30.03.2026
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT		published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2002/02]
Inventor(s)01 / BERNSTEIN, Peter, Robert
1800 Concord Pike
Wilmington, DE 19850-5437 / US
 [2002/02]
Application number, filing date00914298.503.04.2000
[2002/02]
WO2000GB01252
Priority number, dateGB1999000757106.04.1999         Original published format: GB 9907571
[2002/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0059873
Date:12.10.2000
Language:EN
[2000/41]
Type: A1 Application with search report 
No.:EP1169302
Date:09.01.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 12.10.2000 takes the place of the publication of the European patent application.
[2002/02]
Type: B1 Patent specification 
No.:EP1169302
Date:29.09.2004
Language:EN
[2004/40]
Search report(s)International search report - published on:EP12.10.2000
ClassificationIPC:C07C255/57, C07D295/12, A61K31/275, A61P11/00, A61P25/00, A61P1/00, A61P29/00
[2002/02]
CPC:
C07D295/125 (EP,US); C07C255/57 (EP,KR,US); A61P1/00 (EP);
A61P1/08 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P17/00 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P25/06 (EP); A61P25/14 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/02]
Extension statesALNot yet paid
LT06.11.2001
LV06.11.2001
MKNot yet paid
RO06.11.2001
SI06.11.2001
TitleGerman:N-(2-PHENYL-4-AMINO-BUTYL)-1-NAPHTHAMIDE ALS NEUROKININ-1 REZEPTORANTAGONISTEN[2002/02]
English:N-(2-PHENYL-4-AMINO-BUTYL)-1-NAPHTHAMIDES AS NEUROKININ-1 RECEPTOR ANTAGONISTS[2002/02]
French:N-(2-PHENYL-4-AMINO-BUTYL)-1-NAPHTHAMIDES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE LA NEUROKININE-1[2002/02]
Entry into regional phase06.11.2001National basic fee paid 
06.11.2001Designation fee(s) paid 
06.11.2001Examination fee paid 
Examination procedure20.10.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.11.2001Examination requested  [2002/02]
24.01.2003Despatch of a communication from the examining division (Time limit: M04)
21.05.2003Reply to a communication from the examining division
08.04.2004Communication of intention to grant the patent
16.07.2004Fee for grant paid
16.07.2004Fee for publishing/printing paid
Opposition(s)30.06.2005No opposition filed within time limit [2005/38]
Fees paidRenewal fee
02.05.2002Renewal fee patent year 03
02.05.2003Renewal fee patent year 04
03.05.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
PT28.02.2005
CY03.04.2005
LU03.04.2005
IE04.04.2005
MC30.04.2005
[2008/03]
Former [2007/27]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
CY03.04.2005
LU03.04.2005
IE04.04.2005
MC30.04.2005
Former [2007/26]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
CY03.04.2005
LU03.04.2005
IE04.04.2005
Former [2007/20]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
CY03.04.2005
IE04.04.2005
LU30.04.2005
Former [2007/08]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
IE04.04.2005
LU30.04.2005
Former [2006/25]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
IE04.04.2005
Former [2006/14]AT29.09.2004
BE29.09.2004
FI29.09.2004
NL29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
Former [2005/46]AT29.09.2004
BE29.09.2004
FI29.09.2004
DK29.12.2004
GR29.12.2004
ES09.01.2005
Former [2005/28]AT29.09.2004
BE29.09.2004
FI29.09.2004
GR29.12.2004
ES09.01.2005
Former [2005/27]AT29.09.2004
FI29.09.2004
GR29.12.2004
ES09.01.2005
Former [2005/18]AT29.09.2004
FI29.09.2004
GR29.12.2004
Former [2005/13]AT29.09.2004
FI29.09.2004
Former [2005/11]FI29.09.2004
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.